8-KAcquisitions & DispositionsRegulation FDExhibits & Filings

FISERV INC 8-K Report, Acquisition Completed (Jan 11, 2008)

Filed January 11, 2008For Securities:FISV

Summary

Fiserv, Inc. has announced the completion of a significant divestiture, selling its Fiserv Health business to United Healthcare Services, Inc. for approximately $721 million in cash. This transaction marks a strategic shift for Fiserv, indicating a focus on streamlining its operations and potentially reallocating capital. The sale includes a comprehensive suite of health plan administration, management, and related services, such as third-party administration, prescription benefits, care management, and claims resolution. Investors should note that this divestiture significantly alters Fiserv's business mix and should consider the implications for future growth strategies and financial performance. The substantial cash proceeds from this sale provide Fiserv with considerable financial flexibility. This could be utilized for debt reduction, share repurchases, strategic acquisitions in core business areas, or increased dividend payouts. The market will likely be keen to understand Fiserv's plans for deploying this capital and how this strategic decision aligns with its long-term vision for value creation for shareholders. The accompanying pro forma financial statements will be crucial for understanding the financial impact of this transaction on Fiserv's ongoing operations.

Key Highlights

  • 1Fiserv, Inc. completed the sale of its Fiserv Health business to United Healthcare Services, Inc. on January 10, 2008.
  • 2The transaction generated approximately $721 million in cash proceeds for Fiserv.
  • 3The sale includes various health plan administration and management services, such as third-party administration, prescription benefits, and care management.
  • 4This divestiture represents a strategic decision by Fiserv to exit the health services sector.
  • 5The cash infusion provides Fiserv with significant financial flexibility for future strategic initiatives.
  • 6Accompanying pro forma financial statements are filed to reflect the impact of the transaction.

Frequently Asked Questions

The primary purpose of this 8-K filing was to announce and report on the completion of Fiserv's sale of its Fiserv Health business to United Healthcare Services, Inc. for approximately $721 million in cash.

The sale included Fiserv Health Plan Administration, Fiserv Health Plan Management, Innoviant (prescription benefits), Innoviant Pharmacy, Avidyn Health (care management), BP, Inc. (stop loss products), Innovative Cost Solutions (claims resolution), J.W. Hutton, Inc. (subrogation/recovery), and ppoONE, Inc. (claim re-pricing).

The substantial cash proceeds provide Fiserv with significant financial flexibility. Investors will be looking for management's plans regarding the deployment of this capital, which could include debt reduction, share repurchases, strategic acquisitions, or increased shareholder returns.

This divestiture suggests a strategic shift for Fiserv, indicating a focus on streamlining its operations and potentially concentrating on its core businesses. Investors should analyze Fiserv's future strategic announcements and financial reports to understand how this sale aligns with its long-term growth objectives.